Please enable JavaScript to continue using this application.

Compare $CRVO vs $DWTX | Chartloom

Compare

$CRVO vs $DWTX

CervoMed Inc · Dogwood Therapeutics Inc

CRVO

CervoMed Inc

DWTX

Dogwood Therapeutics Inc

Compare $CRVO vs $DWTX

Comparing CervoMed Inc and Dogwood Therapeutics Inc

CRVOCervoMed Inc

DWTXDogwood Therapeutics Inc

CRVOCervoMed Inc

Market cap

$44M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-95.7%

YTD performance

-58.7%

52W performance

-63.8%

FCF yield

-64.2%

DWTXDogwood Therapeutics Inc

Market cap

$47M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.0%

52W performance

-78.1%

FCF yield

-32.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRVO

DWTX

Detailed metrics comparison

CRVO

CervoMed Inc

DWTX

Dogwood Therapeutics Inc

Market Cap

CRVO$44M

DWTX$47M

Enterprise Value

CRVO$21M

DWTX$37M

Price

CRVO$3.22

DWTX$1.40

P/E Ratio

CRVON/A

DWTXN/A

P/S Ratio

CRVO131.50x

DWTX0.00x

EV/Sales

CRVO63.70x

DWTX0.00x

EV/EBITDA

CRVO0.00x

DWTX0.00x

P/B Ratio

CRVO1.99x

DWTX0.73x

P/FCF Ratio

CRVON/A

DWTXN/A

EV/FCF

CRVO-0.75x

DWTX-2.48x

PEG Ratio

CRVON/A

DWTXN/A

Forward P/E (NTM)

CRVON/A

DWTXN/A

Forward P/S (NTM)

CRVON/A

DWTXN/A

Revenue (TTM)

CRVO$331K

DWTX$0

Revenue Growth (YoY)

CRVO-95.7%

DWTXN/A

Forward Rev Growth

CRVO2153.6%

DWTX613.9%

Gross Margin (TTM)

CRVO0.0%

DWTX0.0%

Operating Margin (TTM)

CRVO0.0%

DWTX0.0%

EBITDA Margin (TTM)

CRVO-9406.8%

DWTX0.0%

Net Margin (TTM)

CRVO-9160.8%

DWTX0.0%

FCF Margin (TTM)

CRVO-8444.8%

DWTXN/A

Net Income (TTM)

CRVO$-30M

DWTX$-25M

FCF (TTM)

CRVO$-28M

DWTX$-15M

EPS (TTM)

CRVO-$2.96

DWTX$0.00

ROE (TTM)

CRVO-15602.0%

DWTX-3591.0%

ROA (TTM)

CRVO-12834.0%

DWTX-3028.0%

ROIC (TTM)

CRVO-15602.0%

DWTX-3591.0%

Cash

CRVO$22M

DWTX$10M

Debt

CRVO$0

DWTX$0

Net Cash/Debt

CRVO$22M

DWTX$10M

Current Ratio (TTM)

CRVO8.57x

DWTX3.89x

Quick Ratio (TTM)

CRVO8.36x

DWTX3.41x

Debt/Equity (TTM)

CRVO0.00x

DWTX0.00x

Debt/Assets (TTM)

CRVO0.0%

DWTX0.0%

Interest Coverage (TTM)

CRVON/A

DWTXN/A

Net Debt/EBITDA (TTM)

CRVO0.00x

DWTX0.00x

Beta

CRVO-0.69

DWTX2.14

52W Performance

CRVO-63.8%

DWTX-78.1%

YTD Performance

CRVO-58.7%

DWTX-67.0%

% from 52W High

CRVO-67.8%

DWTX-80.1%

% from 52W Low

CRVO51.2%

DWTX9.4%

Asset Turnover (TTM)

CRVO0.07x

DWTX0.00x

FCF Yield (TTM)

CRVO-64.2%

DWTX-32.1%

Earnings Yield (TTM)

CRVO-69.7%

DWTX-52.1%

Dividend Yield (TTM)

CRVON/A

DWTXN/A

Rule of 40

CRVO-8,540.5

DWTX0.0

EV/GP/RG

CRVON/A

DWTXN/A

Ticker research

View CRVO research View DWTX research

Metric	CRVO CervoMed Inc	DWTX Dogwood Therapeutics Inc
Market & Valuation
Market Cap	$44M	$47M
Enterprise Value	$21M	$37M
Price	$3.22	$1.40
P/E Ratio	N/A	N/A
P/S Ratio	131.50x	0.00x
EV/Sales	63.70x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.99x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-2.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$331K	$0
Revenue Growth (YoY)	-95.7%	N/A
Forward Rev Growth	2153.6%	613.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9406.8%	0.0%
Net Margin (TTM)	-9160.8%	0.0%
FCF Margin (TTM)	-8444.8%	N/A
Net Income (TTM)	$-30M	$-25M
FCF (TTM)	$-28M	$-15M
EPS (TTM)	-$2.96	$0.00
ROE (TTM)	-15602.0%	-3591.0%
ROA (TTM)	-12834.0%	-3028.0%
ROIC (TTM)	-15602.0%	-3591.0%
Financial Health
Cash	$22M	$10M
Debt	$0	$0
Net Cash/Debt	$22M	$10M
Current Ratio (TTM)	8.57x	3.89x
Quick Ratio (TTM)	8.36x	3.41x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.69	2.14
52W Performance	-63.8%	-78.1%
YTD Performance	-58.7%	-67.0%
% from 52W High	-67.8%	-80.1%
% from 52W Low	51.2%	9.4%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.00x
FCF Yield (TTM)	-64.2%	-32.1%
Earnings Yield (TTM)	-69.7%	-52.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,540.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRVO research	View DWTX research

Valuation

P/S Ratio

DWTX

0.00x

CRVO

131.50x

EV/FCF

DWTX

-2.48x

CRVO

-0.75x

Growth & revenue

Revenue Growth TTM

CRVO

-95.7%

Forward Revenue Growth

CRVO

2153.6%

DWTX

613.9%

Profitability & performance

Gross Margin

CRVO

0.0%

DWTX

0.0%

ROE

DWTX

-3591.0%

CRVO

-15602.0%

FCF Yield %

DWTX

-32.1%

CRVO

-64.2%

52-Week Performance

CRVO

-63.8%

DWTX

-78.1%

Detailed metrics comparison

CRVO

CervoMed Inc

DWTX

Dogwood Therapeutics Inc

Market Cap

CRVO$44M

DWTX$47M

Enterprise Value

CRVO$21M

DWTX$37M

Price

CRVO$3.22

DWTX$1.40

P/E Ratio

CRVON/A

DWTXN/A

P/S Ratio

CRVO131.50x

DWTX0.00x

EV/Sales

CRVO63.70x

DWTX0.00x

EV/EBITDA

CRVO0.00x

DWTX0.00x

P/B Ratio

CRVO1.99x

DWTX0.73x

P/FCF Ratio

CRVON/A

DWTXN/A

EV/FCF

CRVO-0.75x

DWTX-2.48x

PEG Ratio

CRVON/A

DWTXN/A

Forward P/E (NTM)

CRVON/A

DWTXN/A

Forward P/S (NTM)

CRVON/A

DWTXN/A

Revenue (TTM)

CRVO$331K

DWTX$0

Revenue Growth (YoY)

CRVO-95.7%

DWTXN/A

Forward Rev Growth

CRVO2153.6%

DWTX613.9%

Gross Margin (TTM)

CRVO0.0%

DWTX0.0%

Operating Margin (TTM)

CRVO0.0%

DWTX0.0%

EBITDA Margin (TTM)

CRVO-9406.8%

DWTX0.0%

Net Margin (TTM)

CRVO-9160.8%

DWTX0.0%

FCF Margin (TTM)

CRVO-8444.8%

DWTXN/A

Net Income (TTM)

CRVO$-30M

DWTX$-25M

FCF (TTM)

CRVO$-28M

DWTX$-15M

EPS (TTM)

CRVO-$2.96

DWTX$0.00

ROE (TTM)

CRVO-15602.0%

DWTX-3591.0%

ROA (TTM)

CRVO-12834.0%

DWTX-3028.0%

ROIC (TTM)

CRVO-15602.0%

DWTX-3591.0%

Cash

CRVO$22M

DWTX$10M

Debt

CRVO$0

DWTX$0

Net Cash/Debt

CRVO$22M

DWTX$10M

Current Ratio (TTM)

CRVO8.57x

DWTX3.89x

Quick Ratio (TTM)

CRVO8.36x

DWTX3.41x

Debt/Equity (TTM)

CRVO0.00x

DWTX0.00x

Debt/Assets (TTM)

CRVO0.0%

DWTX0.0%

Interest Coverage (TTM)

CRVON/A

DWTXN/A

Net Debt/EBITDA (TTM)

CRVO0.00x

DWTX0.00x

Beta

CRVO-0.69

DWTX2.14

52W Performance

CRVO-63.8%

DWTX-78.1%

YTD Performance

CRVO-58.7%

DWTX-67.0%

% from 52W High

CRVO-67.8%

DWTX-80.1%

% from 52W Low

CRVO51.2%

DWTX9.4%

Asset Turnover (TTM)

CRVO0.07x

DWTX0.00x

FCF Yield (TTM)

CRVO-64.2%

DWTX-32.1%

Earnings Yield (TTM)

CRVO-69.7%

DWTX-52.1%

Dividend Yield (TTM)

CRVON/A

DWTXN/A

Rule of 40

CRVO-8,540.5

DWTX0.0

EV/GP/RG

CRVON/A

DWTXN/A

Ticker research

View CRVO research View DWTX research

Metric	CRVO CervoMed Inc	DWTX Dogwood Therapeutics Inc
Market & Valuation
Market Cap	$44M	$47M
Enterprise Value	$21M	$37M
Price	$3.22	$1.40
P/E Ratio	N/A	N/A
P/S Ratio	131.50x	0.00x
EV/Sales	63.70x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.99x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.75x	-2.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$331K	$0
Revenue Growth (YoY)	-95.7%	N/A
Forward Rev Growth	2153.6%	613.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9406.8%	0.0%
Net Margin (TTM)	-9160.8%	0.0%
FCF Margin (TTM)	-8444.8%	N/A
Net Income (TTM)	$-30M	$-25M
FCF (TTM)	$-28M	$-15M
EPS (TTM)	-$2.96	$0.00
ROE (TTM)	-15602.0%	-3591.0%
ROA (TTM)	-12834.0%	-3028.0%
ROIC (TTM)	-15602.0%	-3591.0%
Financial Health
Cash	$22M	$10M
Debt	$0	$0
Net Cash/Debt	$22M	$10M
Current Ratio (TTM)	8.57x	3.89x
Quick Ratio (TTM)	8.36x	3.41x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.69	2.14
52W Performance	-63.8%	-78.1%
YTD Performance	-58.7%	-67.0%
% from 52W High	-67.8%	-80.1%
% from 52W Low	51.2%	9.4%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.00x
FCF Yield (TTM)	-64.2%	-32.1%
Earnings Yield (TTM)	-69.7%	-52.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,540.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRVO research	View DWTX research